Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Hackshaw

Showing results (131-140 of 167) with videos related to

Pageof 17
Sort By:
Lancet (London, England)|October 17, 2024
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trialMary McCormack, Gemma Eminowicz, Dolores Gallardo, et al.
BMJ Open Respiratory Research|September 11, 2025
Differentiating clinically important interstitial lung abnormalities in lung cancer screeningBrintha Selvarajah, Amyn Bhamani, Mehran Azimbagirad, et al.
JAMA Oncology|September 2, 2016
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical TrialPeter W Szlosarek, Jeremy P Steele, Luke Nolan, et al.
Nature Medicine|October 9, 2019
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapseFrancesca Chemi, Dominic G Rothwell, Nicholas McGranahan, et al.
Lancet (London, England)|June 21, 2025
Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trialUjjal Mallick, Kate Newbold, Matthew Beasley, et al.
Nature Medicine|June 5, 2020
Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapseFrancesca Chemi, Dominic G Rothwell, Nicholas McGranahan, et al.
Nature Medicine|June 5, 2020
Publisher Correction: A clonal expression biomarker associates with lung cancer mortalityDhruva Biswas, Nicolai J Birkbak, Rachel Rosenthal, et al.
Nature Cancer|January 9, 2025
Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinomaDhruva Biswas, Yun-Hsin Liu, Javier Herrero, et al.
Nature Medicine|October 9, 2019
A clonal expression biomarker associates with lung cancer mortalityDhruva Biswas, Nicolai J Birkbak, Rachel Rosenthal, et al.
Cancer Discovery|April 6, 2024
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung CancerKatey S S Enfield, Emma Colliver, Claudia Lee, et al.
Pageof 17

Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
Lancet (London, England)|October 17, 2024
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trialMary McCormack, Gemma Eminowicz, Dolores Gallardo, et al.
BMJ Open Respiratory Research|September 11, 2025
Differentiating clinically important interstitial lung abnormalities in lung cancer screeningBrintha Selvarajah, Amyn Bhamani, Mehran Azimbagirad, et al.
JAMA Oncology|September 2, 2016
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical TrialPeter W Szlosarek, Jeremy P Steele, Luke Nolan, et al.
Nature Medicine|October 9, 2019
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapseFrancesca Chemi, Dominic G Rothwell, Nicholas McGranahan, et al.
Lancet (London, England)|June 21, 2025
Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trialUjjal Mallick, Kate Newbold, Matthew Beasley, et al.
Nature Medicine|June 5, 2020
Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapseFrancesca Chemi, Dominic G Rothwell, Nicholas McGranahan, et al.
Nature Medicine|June 5, 2020
Publisher Correction: A clonal expression biomarker associates with lung cancer mortalityDhruva Biswas, Nicolai J Birkbak, Rachel Rosenthal, et al.
Nature Cancer|January 9, 2025
Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinomaDhruva Biswas, Yun-Hsin Liu, Javier Herrero, et al.
Nature Medicine|October 9, 2019
A clonal expression biomarker associates with lung cancer mortalityDhruva Biswas, Nicolai J Birkbak, Rachel Rosenthal, et al.
Cancer Discovery|April 6, 2024
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung CancerKatey S S Enfield, Emma Colliver, Claudia Lee, et al.
Pageof 17